These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Tolerability and immunogenicity of an eleven valent mixed carrier Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid or tetanus protein conjugate vaccine in Finnish and Israeli infants. Dagan R, Kayhty H, Wuorimaa T, Yaich M, Bailleux F, Zamir O, Eskola J. Pediatr Infect Dis J; 2004 Feb; 23(2):91-8. PubMed ID: 14872172 [Abstract] [Full Text] [Related]
6. Pneumococcal vaccination of adults: polysaccharide or conjugate. Med Lett Drugs Ther; 2009 Jun 15; 51(1314):47-8. PubMed ID: 19528887 [No Abstract] [Full Text] [Related]
11. Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine. Lacapa R, Bliss SJ, Larzelere-Hinton F, Eagle KJ, McGinty DJ, Parkinson AJ, Santosham M, Craig MJ, O'Brien KL. Clin Infect Dis; 2008 Aug 15; 47(4):476-84. PubMed ID: 18627249 [Abstract] [Full Text] [Related]
12. [Two pneumococcal vaccines: the 7-valent conjugate vaccine (Prevenar) for children up to the age of 5 years and the 23-valent polysaccharide vaccine (Pneumo 23) for the elderly and specific groups at risk]. de Greeff SC, Sanders EA, de Melker HE, van der Ende A, Vermeer PE, Schouls LM. Ned Tijdschr Geneeskd; 2007 Jun 30; 151(26):1454-7. PubMed ID: 17633974 [Abstract] [Full Text] [Related]
13. [Incidence of invasive pneumococcal infection in children aged less than two years. The heptavalent pneumococcal conjugate vaccine. Situation in Spain]. Blanco Quirós A, Giménez Sánchez F, Asensi Botet F, Bernaola Iturbe E, Martín Fde J, García Pérez J, Garcés Sánchez M, Gómez Campderá JA, Picazo JJ, Pineda Solas V, Comité Asesor de Vacunas de la Asociación Española de Pediatría. An Esp Pediatr; 2002 Oct 30; 57(4):287-9. PubMed ID: 12392660 [No Abstract] [Full Text] [Related]
16. Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children. Kilpi T, Ahman H, Jokinen J, Lankinen KS, Palmu A, Savolainen H, Grönholm M, Leinonen M, Hovi T, Eskola J, Käyhty H, Bohidar N, Sadoff JC, Mäkelä PH, Finnish Otitis Media Study Group. Clin Infect Dis; 2003 Nov 01; 37(9):1155-64. PubMed ID: 14557958 [Abstract] [Full Text] [Related]
17. [Acceptance of the new conjugate vaccines. Meningococcal and pneumococcal vaccines, in the cohort born in 1999, in the North Region of Portugal]. De Queirós L, Castro L, Ferreira MC, Gonçalves G. Acta Med Port; 2004 Nov 01; 17(1):49-53. PubMed ID: 15636727 [Abstract] [Full Text] [Related]